September 20, 2018. Phoenix, AZ. Anju Software, a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent, a provider of software and services for medical affairs and clinical trials.
We are pleased with the execution of Anju’s growth strategy with the acquisition of Sylogent. After having established a leading position in Medical Affairs with the acquisitions of OBA and OpenQ, we believe Sylogent will accelerate Anju’s growth in the Medical Affairs and Clinical Trial segment.Gopi Vaddi on Sylogent, Managing Director, Providence Strategic Growth